HOUSTON, May 25, 2011 /PRNewswire/ — Cyberonics, Inc. (NASDAQ:
CYBX), a global leader in epilepsy management, today announced
it will participate in the 2011 Jefferies Global Healthcare
Conference on Wednesday, June 8, 2011, in New York.
Greg Browne, Cyberonics’ Senior Vice President, Finance &
Chief Financial Officer, will speak to the attendees of the
conference at 10:30 AM Eastern Time. A live audio webcast of
the presentation can be accessed by clicking on the Investor
Relations link on the Cyberonics home page at http://www.cyberonics.com on
June 8, 2011.
About Cyberonics, Inc. and the VNS
Cyberonics, Inc. is a medical technology company with core
expertise in neuromodulation. The company developed and
markets the VNS Therapy System, which is FDA-approved for the
treatment of refractory epilepsy and treatment-resistant
depression. The VNS Therapy System uses a surgically
implanted medical device that delivers electrical pulsed signals to
the vagus nerve. Cyberonics markets the VNS Therapy System in
selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System
is available at www.cyberonics.com.
Greg Browne, CFO
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332